Soluble interleukin-4 receptor (sIL-4R) in allergic diseases

Inflammation Research

Volumn 48, Issue 8, 1999, Pages 425-431

  Renz, H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Allergic inflammation; Atopic dermatitis; Bronchial asthma; Soluble IL 4R

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTHMA; CELL CULTURE; CELL FUNCTION; CLINICAL TRIAL; EFFECTOR CELL; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; LUNG FUNCTION; META ANALYSIS; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-4; MICE; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, INTERLEUKIN-4; RECOMBINANT PROTEINS; SOLUBILITY;

EID: 0032872881     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050482     Document Type: Review

References (50)

1. [1] Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18: 263-6.
2. [2] Matsunoto K, Taki F, Miura M, Matsuzaki M, Takagi K. Serum levels of soluble IL-2R, IL-4, and soluble Fc epsilon RII in adult bronchial asthma. Chest 1994; 105: 681-6.
3. [3] Sun Y, Durham SR, Corrigan CJ, Hamid Q, Kay, AB. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interleukin 2 and interferon γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmaic and normal control subjects. Am J Respir Cell Mol Biol 1995; 12: 477-87.
4. [4] Humbert M, Durham SR, Sun Y, Kimmitt P, Barkans J, Assoufi B, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against intrinsic asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996; 154: 1497-504
5. [5] Robinson D, Hamid Q, Sun Y, Bentley A, Assoufi A, Dourham S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am Rev Respir Dis 1993; 148: 401-6.
6. + helper T cells from atopic subjects. Eur J Immunol 1992; 22: 1615-20.
7. + T lymphocytes in atopic patients. J Immunol 1990; 144: 4651-6.
8. [8] Wierenga EA, Snoek M, Bos JD, Jansen HM, Kapsensberg ML. Comparison of diversity and function of house dust mite-specifiv T lymphocyte clones from atopic and non atopic donors. Eur J Immunol 1990; 20: 1519-26.
9. [9] Parronchi P, Macchia D, Piccinni MP, Biswas P, Simonelli C, Maggi E, et al. Allergen-and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991; 88: 4538-42.
10. [10] Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 1992; 148: 2390-4.
11. [11] Jujo K, Renz H, Abe J, Gelfand EW, Leung DYM. Decreased IFN-γ and increased IL-4 in atopic dermatitis. J Allergy Clin Immunol 1969; 90: 323.
12. [12] Renz H, Jujo K, Bradley KL, Domenico J, Gelfand EW, Leung DYM. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 1992; 99: 403.
13. [13] Shi JZ, Deng JM, Xu H, Nong ZX, Xia CQ, Liu ZM, et al. Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics. Am J Respir Crit Care Med 1998; 157: 1818-21.
14. [14] Lebman DA, Lebman AA, Coffman RL. Interleukin 4 causes istoype switching to IgE in T cell stimulated clonal B cell cultures. J Exp Med 1988; 168: 853-62.
15. [15] Gerondakis S. Structure and expression of murine germ-line immunoglobulin heavy chain transcripts induced by interleukin 4. Proc Natl Acad Sci USA 1990; 87: 1581-5.
16. [16] Gauchat JF, Lebman DA, Coffman RL, Bascan H, de Vries JE. Structure and expression of germline ε transcripts in human B cells induced by interleukin 4 to switch to IgE production. J Exp Med 1990; 172: 463-73.
17. [17] Snapper CM, Paul WE. Interferon-and B cell stimulatory factor 1 reciprocally regulate Ig isotype production. Science 1987; 236: 944-7.
18. 2. Proc Natl Acad Sci USA 1988; 85: 6880-4.
19. [19] Thyphronitis G, Tsokos GC, June CH, Levine AD, Finkelman FD. IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon. Proc Natl Acad Sci USA 1989; 86: 5580-4.
20. [20] Paganelli R, Scala E, Capobianchi MR, Fanales-Belasio E, D'Offizi G, Fiorilli M, et al. Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis. Clin Exp Immunol 1991; 84: 28-33.
21. [21] Tang M, Kemp A, Varigos G. IL-3 and interferon-gamma production in children with atopic disease. Clin Exp Immunol 1993; 92: 120-4.
22. [22] Romagnani S, Maggi E, Del Prete P, Parronchi P, Macchia D, Tiri A, et al. Role of interleukin 4 and gamma interferon in the regulation of human IgE synthesis: possible alterations in atopic patients. Int Arch Allergy Appl Immunol 1989; 88: 111-3.
23. [23] Rousset F, Robert J, Andary M, Bonnin JP, Souillet G, Chrétien I, et al. Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol 1991; 87: 58-69.
24. [24] Boguniewicz M, Jaffe HS, Izu A, Sullivan MJ, York D, Geha RS, et al. Recombinant gamma interferon in treatments of patients with atopic dermatitis and elevated IgE levels. Am J Med 1990; 88: 365-9.
25. [25] Hanifin JM, Schneider LC, Leung DYM, Ellis CN, Jaffe HS, Izu AE, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993; 28: 189-97.
26. [26] Reinhold U, Wehrmann W, Kukel S, Kreysel HW. Recombinant interferon-γ in severe atopic dermatitis. Lancet 1990; 26: 1282.
27. [27] Finkelman FD, Urban JF, Beckmann P, Schooley KA, Holmes JM, Katona IM. Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody. Int Immunol 1991; 3: 599-607.
28. [28] Finkelman FD, Katona IM, Urban JF Jr, Holmes J, Ohara J, Tung, AS, et al. Interleukin-4 is required to generate and sustain in vivo IgE responses. J Immunol 141: 2335.
29. [29] Sato TA, Widmer MB, Finkelman FD, Madani H, Jacobs C, Grabstein KH, et al. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J Immunol 1993; 150: 2717-23.
30. [30] Maliszewski CR, Sato TA, Vanden Bos T, Waugh S, Dower SK, Slack J, et al. Cytokine receptors and B cell functions. 1. Recombinant soluble receptors specifically inhibit IL-1 and IL-4 induced B cell activities in vitro. J Immunol 1990; 144: 3028-33.
31. [31] Garrone P, Djossou O, Galizzi JP, Banchereau J. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. Eur J Immunol 1991, 21: 1365-9.
32. [32] Mosley B, Beckman MP, March CJ, Idzerda RL, Gimpel SD, VandenBos T, et al. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 1989; 59: 335.
33. [33] Beckmann MP, Cosman D, Fanslow W, Maliszewski CR, Lyman SD. The interleukin-4 receptor: structure, function and signal transduction. Chem Immunol 1992; 51: 107.
34. [34] Fernandez-Botran R, Vietta ES. A soluble high-affinity interleukin-4-binding protein is present in the biological fluids of mice. Proc Natl Acad Sci USA 1990; 87: 4202.
35. [35] Chilton PM, Fernandez-Botran R. Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4. J Immunol 1993; 151: 5907-17.
36. [36] Fanslow WC, Clifford KN, Park LS, Rubin AS, Voice RF, Beckman MP, et al. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J Immunol 1991; 147: 535.
37. [37] Fernandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J 1991; 5:2567.
38. [38] Fernandez-Botran R, Vietta ES. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J Exp Med 1991; 174: 673.
39. [39] Renz H, Smith HR, Henson JE, Ray BS, Irvin CG, Gelfand EW. Aerosolized antigen exposure without adjuvant causes increased IgE production and airways hyperresponsiveness in the mouse. J All Clin Immunol 1992; 89: 1127-38.
40. [40] Renz H, Saloga J, Bradley KL, Loader J, Greenstein JL, Larsen GL, Gelfand EW. Specific Vβ T-cell subsets mediate the immediate hypersensitivity response to ragweed allergen. J Immunol 1994; 151: 1907-17.
41. [41] Herz U, Braun A, Rückert R, Renz H. Various immunological phenotypes are associated with increased airway responsiveness. Clin Exp Allergy 1997; 28: 625-34.
42. [42] Saloga J, Renz H, Lack G, Bradley K, Larsen G, Gelfand EW. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen. J Clin Invest 1993; 91: 133-40.
43. [43] Larsen GL, Renz H, Loader JE, Bradley K, Gelfand EW. Airway response to electrical field stimulation in sensitized inbred mice: passive transfer of increased responsiveness with peribronchial lymph nodes. J Clin Invest 1992; 89: 747-52.
44. [44] Renz H, Bradley K, Marrack P, Gelfand EW. T cells expressing variable elements of T-cell receptor β8 and β2 chain regulate murine IgE production. Proc Natl Acad Sci USA 1992; 89: 6438-442.
45. [45] Renz H, Bradley K, Saloga J, Loader J, Larsen GL, Gelfand EW. T cells expressing specific V elements regulate IgE production and airways responsiveness in vivo. J Exp Med 1993; 177: 1175-80.
46. [46] Renz H, Enssle K, Kurrle R, Gelfand EW. Inhibition of allergen-induced and allergen-specific IgE and IgG1 production by soluble IL-4 receptor (sIL-4R). Int Arch All Immunol 1995; 106: 45-54.
47. [47] Renz H, Bradley K, Enssle K, Loader JA, Larsen G, Gelfand EW. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Int Arch Allergy Immunol 1996; 109: 167-76.
48. [48] Nasert S, Millner M, Enssle KH, Wahn U, Renz H. Differential modulation of T cell functions by soluble IL-4R (sIL-4R) in two cases of severe atopic dermatitis. Pediatr Allergy Immunol 1996; 7: 91-4.
49. [49] Herz U, Schnoy N, Borelli S, Weigl L, Käsbohrer U, Daser A, et al. A human-SCID mouse model for allergic immune responses: bacterial superantigen enhances skin inflammation and suppress IgE production. J Invest Dermatol 1998; 110: 224-31.
50. [50] Borish LC, Nelson HS, Lanz M, Claussen LR, Martin DW, Garrison L. Phase I/II study of Interleukin-4 Receptor (IL-4R) in moderate asthma. J All Clin Immunol 1998; 101: S8-9.